Business
BioSpectrum Asia
Repligen introduces next-generation chromatography resins
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, has announced the launch of three new high-performance chromatography resins:
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Hanahealth by DSS Imagetech launches GERI Time-Lapse Incubator in India
Hanahealth by DSS Imagetech, the authorised partner of Sydney-based Genea Biomedx, has launched the advanced GERI Time-Lapse Incubator pan India. GERI, the nextgeneration Time Lapse embryo culture system from Genea Biomedx, is ideal for IVF clinics, labs adopting digital transformation, centres working toward accreditation, and research-focused fertility groups as it enables them to modernise their processes and improve IVF outcomes.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Biotechnology to Drive Next Industrial Revolution: Dr Jitendra Singh
\"Biotechnology will play a defining role in shaping the next industrial revolution and will be a key driver of global and Indian economic growth\", said Dr Jitendra Singh, the Union Minister of State (Independent Charge) for Science and Technology.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Cartherics names Dr lan Nisbet as CEO
Australia-based Cartherics, a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women's diseases, with lead programmes in ovarian cancer and endometriosis, has announced the appointment of Dr Ian Nisbet as Chief Executive Officer, as part of a planned leadership transition.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Neurophet ropes in Josh Cohen as Head of Americas Business
South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, has appointed Josh Cohen, a veteran executive from leading global medical device companies, as new Head of Americas Business.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
India's Final Mile to TB Elimination
As the target year 2025 draws to a close, the Government of India has intensified and consolidated nationwide efforts to eliminate tuberculosis (TB) through the TB-Mukt Bharat Abhiyaan, implemented under the National Tuberculosis Elimination Programme (NTEP). India's decision to advance the TB elimination timeline ahead of global targets has driven sustained reforms across detection, treatment, prevention, nutrition support, and community engagement.
2 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Korea builds AI-engineered nasal spray antiviral platform
A research team at Korea Advanced Institute of Science and Technology has successfully developed a nasal (intranasal) antiviral platform using artificial intelligence (AI) technology to overcome the existing limitations of interferonlambda treatments, namely, being weak against heat and disappearing quickly from the nasal mucosa.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
"Industry needs to evolve and invest in ADC payloads with more differentiated mechanisms of action
Antibody drug conjugates (ADCs) are becoming highly valuable in the market, with currently 15 approved ADCs targeting 16 different indications for haematological and solid tumour malignancies. With key components of ADCs, such as mAbs, linkers, payloads, and conjugation technologies, undergoing rapid advancements, a solid foundation has been laid for future research and development in this field, particularly in North America which is the largest market shareholder for ADCs. US recently wrapped up the world's largest & definitive Antibody-Drug Conjugate event, World ADC, held in November 2025, highlighting the development of novel ADCs through key market players, and a surge in patent application filing for ADCs. Dr Allan Jordan, Vice President of Oncology Drug Discovery at Sygnature Discovery, UK spoke in detail with BioSpectrum Asia about the future outlook of ADCs.
4 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Cytiva and Fida Biosystems collaborate to improve molecular insight for faster drug discovery
Cytiva, a Danaher company and leader in the life sciences industry, and Fida Biosystems, a Danish company specialising in molecular analysis, have joined forces to expand analytical capabilities for protein research.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
BioSpectrum Excellence Awards Highlight Strength and Future of India's Biotechnology Sector
Former Secretary, Department of Biotechnology (DBT), Government of India, Dr Renu Swarup, underscored the importance of recognising excellence across the biotechnology ecosystem while chairing the jury at the BioSpectrum Excellence Awards.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
How Precision Medicine Is Reshaping Cancer Care
Despite major advances in cancer detection and treatment, high recurrence rates and progression to advanced disease continue to challenge outcomes across Asia-making precision medicine a critical catalyst for shifting cancer care from disease management toward treat-to-cure.
2 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
New tool by Singapore reveals hidden metabolic weakness in blood cancers
Scientists from Duke-NUS Medical School and their international collaborators have developed a new computational tool that maps how gene pathways interact in complex biological systems.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Hong Kong develops breakthrough test aiding early autism diagnosis
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has announced the official launch of the world's first AI-Powered Multikingdom Microbial Biomarkers Technology (MSX Metagenie), in collaboration with MicroSigX Biotech Diagnostic Limited, a CUHK spin-off.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Japan designs innovative diagnostic technology using machine learning
Scientists at Japan's University of Tokyo have developed an innovative diagnostic technology that analyses the full drying process of a blood droplet using machine learning.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
India creates new method for better and comprehensive treatment of Alzheimer's disease
Researchers at Mohali-based Institute of Nano Science and Technology (INST), an autonomous institute of the Department of Science and Technology (DST), Government of India, have consolidated nanotechnology, molecular biology and computational modelling to develop a multifaceted therapy for Alzheimer's disease.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Nona Biosciences appoints Dr Hongjiang Miao as Chief AI Officer
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from Idea to IND, has announced the appointment of Dr Hongjiang Miao as Chief AI Officer.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
There are talent shortages in specialised modalities such as ADCs, peptides, and computational biology
As the Asia Pacific (APAC) contract development and manufacturing organisation (CDMO) sector continues to expand rapidly due to rising R&D investment, strong biotech formation, increased demand for Investigational New Drug (IND) - enabling and early Chemistry, Manufacturing, and Controls (CMC) services, and national incentives for biomanufacturing, KBI Biopharma is focused on targeted expansion into Japan, Korea, Taiwan, and Australia, for improving local engagement and enhancing access to global network. BioSpectrum Asia spoke to Katie Edgar, Chief Business Officer, KBI Biopharma to learn more about the company's growth plans in 2026, and about the growth opportunities in store for the CDMO market within the APAC region.
4 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
MMA Spectrum Foundation Launches Initiative to Support Startups and Young Innovators
The MMA Spectrum Foundation, an initiative of the MM Activ Group, has announced its commitment to encouraging startups by providing structured support to young innovators with entrepreneurial vision.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Kyowa Kirin names Dr Abdul Mullick as President and CEO
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has announced the Board of Directors' decision to appoint Abdul Mullick, PhD, currently President and Chief Operating Officer (COO), to the role of President and Chief Executive Officer (CEO).
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Advanced brain imaging reveals promise of new drug for Parkinson's disease
Australia's University of Queensland (UQ) researchers have developed a promising new anti-inflammatory drug and, for the first time, used advanced imaging to watch its effects unfold inside the living brain, a breakthrough that could accelerate treatments for Parkinson's disease.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Thermo Fisher Scientific expands Gibco Bacto portfolio
Thermo Fisher Scientific Inc. has announced the launch of Gibco Bacto CD Supreme FPM Plus and Gibco Bacto CD Supreme Feed (2X), two next-generation chemically-defined formulations that expand the Gibco Bacto CD portfolio to enhance and simplify plasmid DNA and recombinant protein production using Escherichia coli (E. coli).
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Agilent and Monash University Malaysia strengthen partnership with new BioDiscovery Hub
Agilent Technologies Inc. has announced the expansion of their strategic collaboration with Monash University in Malaysia to establish a state-of-the-art MUMPMP-Agilent BioDiscovery Hub aimed at accelerating regional biotechnology research and innovation.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Pixelgen Technologies further expands Asia presence
Pixelgen Technologies, Inc. and MDXK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion services, have announced a distribution agreement to bring Pixelgen's Proxiome Kit to life sciences researchers in South Korea.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Thyrocare announces appointment of Dr Ramesh Kinha as Chief Operating Officer
India-based Thyrocare Technologies has appointed Dr Ramesh Kinha as its Chief Operating Officer, further strengthening its leadership team as the company continues to scale its operations across India.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Indian S&T Minister Dr Jitendra Singh Honours Life Sciences Stalwarts With BioSpectrum India Excellence Awards 2025
The Union Minister of State (Independent Charge) Science & Technology, Dr Jitendra Singh, honoured the leading figures of the life sciences industry for their contributions and achievements for the year 2023-24 and 2024-25 during BioSpectrum India Excellence Awards 2025 event, organised by BioSpectrum India, an integrated B2B media platform for the bioscience industry, and MMA Spectrum Foundation, in New Delhi on December 5.
3 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
DHL Express enhances Asia Pacific leadership team with strategic appointments
Pharma logistics company DHL Express has made two key leadership appointments in Asia Pacific-Chee Choong Ng as Senior Vice President of Human Resources (HR) for Asia Pacific, and Samuel Lee as Managing Director for Taiwan.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
WHO and the European Commission expand partnership to combat AMR
The World Health Organization (WHO) and the European Commission's Health Emergency Preparedness Authority (HERA) have signed a €3.5 million agreement to expand their partnership to combat antimicrobial resistance (AMR) under the EU4Health programme.
1 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Momentum in Motion: What Will Shape APAC's Life Sciences Landscape in 2026?
Asia-Pacific's life sciences sector is growing rapidly, driven by its scale, diversity and resilience. Accelerating demographic change and strong investment in innovation position the region to outpace global growth and shape the future of healthcare.
5 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Reshaping Asia's Healthcare with mRNA Innovation
The COVID-19 pandemic acted as both a challenge and a catalyst, serving as a testbed that fundamentally reshaped the biotechnology landscape across Asia and beyond. What emerged during this period was not just a breakthrough moment for mRNA, but the early foundation of a broader transformation that is still unfolding.
2 min |
BioSpectrum Asia Jan 2026
BioSpectrum Asia
Japan Pushes Startups to Power the Next Biotech Cycle
In recent years, the Japanese government has rolled out a series of initiatives to reshape the country's biopharma ecosystem. These include expanded venture funding, targeted subsidies for drug development, and tax incentives for investors, entrepreneurs, and startup employees.
4 min |